Literature DB >> 19589285

Clinical and histological modifications in osteopetrotic bone: a review.

L Scaramuzzo, L Messuti, P F Manicone, L Raffaelli, B Rossi, P Gallenzi, D Berardi, G Maccauro.   

Abstract

Osteopetrosis is one cause of diffuse osteosclerosis and bone fragility due to abnormal remodelling rate and balance. It may cause some serious skeletal abnormalities, with particular respect to long bones, and oral complications such as osteomyelitis and exposed necrotic bone. Orthopaedists and dentists should be aware of patients with the disease because of its effect on osteoclast function, which results in impaired wound healing. The purpose of this paper is to review the aetiology, pathogenesis and bone remodelling of osteopetrosis leading to some guidance for orthopaedic surgeons and dentists on the management of patients with osteopetrosis, with particular attention to fractures.

Entities:  

Mesh:

Year:  2009        PMID: 19589285

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  4 in total

Review 1.  Novel insights into the relationship between diabetes and osteoporosis.

Authors:  Francisco J A de Paula; Mark C Horowitz; Clifford J Rosen
Journal:  Diabetes Metab Res Rev       Date:  2010-10-11       Impact factor: 4.876

2.  Guided growth for valgus deformity correction of knees in a girl with osteopetrosis: a case report.

Authors:  Dmitry Popkov
Journal:  Strategies Trauma Limb Reconstr       Date:  2017-06-07

3.  Surgical treatment of osteopetrosis-related femoral fractures: two case reports and literature review.

Authors:  Ahmet Aslan; Yakup Barbaros Baykal; Emin Uysal; Tolga Atay; Vecihi Kirdemir; Metin Lütfi Baydar; Nevres Hürriyet Aydoğan
Journal:  Case Rep Orthop       Date:  2014-01-21

4.  Treatment for subtrochanteric fracture and subsequent nonunion in an adult patient with osteopetrosis: A case report and review of the literature.

Authors:  Hao Yang; Guo-Xi Shao; Zhen-Wu Du; Zheng-Wei Li
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.